COPD disease and malnutrition;EPOC y malnutrición

Archivos de Bronconeumologia

Volumn 45, Issue SUPPL.5, 2009, Pages 31-35

  Macario, Ciro Casanova ^a   Tajes, Juan Pablo de Torres ^b   Palmero, María Ángeles Martín ^c  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c HOSPITAL SAN PEDRO   (Spain)

Author keywords

COPD; Malnutrition

Indexed keywords

ARTICLE; BODY MASS; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; DISEASE SEVERITY; EXERCISE; FORCED EXPIRATORY VOLUME; GENETIC HETEROGENEITY; HUMAN; IMPEDANCE; LEAN BODY WEIGHT; LONGITUDINAL STUDY; MALNUTRITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL SUPPORT; PREVALENCE; PROGNOSIS; PULMONARY REHABILITATION; RELIABILITY; RISK FACTOR; WEIGHT REDUCTION;

HUMANS; MALNUTRITION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 72049106386     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S0300-2896(09)72861-3     Document Type: Article

References (41)

1. Peces-Barba G., Barberá J.A., Agustí A., Casanova C., Casas A., Izquierdo J.L., et al. Guía de práctica clínica de diagnóstico y tratamiento de la Enfermedad Pulmonar Obstructiva Crónica. Normativa SEPAR-ALAT. Arch Bronconeumol 44 (2008) 271-281
2. Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist A.S., Calverley P., et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for chronic obstructive pulmonary disease (GOLD). Workshop summary. Am J Respir Crit Care Med 176 (2007) 532-555
3. King D.A., Cordova F., and Scharf S.M. Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 5 (2008) 519-523
4. Schols A.M., Broekhuizen R., Weling-Scheepers C.E., and Wouters E.F. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82 (2005) 53-59
5. Ischaki E., Papatheodorou G., Gaki E., Papa I., Koulouris N., and Loukides S. Body mass and fat-free mass indices in COPD: Relation with variables expressing disease severity. Chest 132 (2007) 164-169
6. Schols A.M., Wouters E.F., Soeters P.B., and Westerterp K.R. Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 53 (1991) 421-424
7. Janssen I., Heymsfield S.B., Baumgartner R.N., and Ross S. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 89 (2000) 465-471
8. Shutz Y., Kyle U.U.G., and Pichard C. Fat-free mass index and fat mass index percentiles in caucasians aged 18-98 y. Int J Obesity 26 (2002) 953-960
9. Wagner P.D. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 31 (2008) 492-501
10. Vestbo J., Prescott E., Almdal T., Dahl M., Nordestgaard B.G., Andersen T., et al. Body mass, fat-free body mass and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 173 (2006) 79-83
11. Soler J.J., Sanchez L., Roman P., Martinez M.A., and Perpiña M. Prevalencia de la desnutrición en pacientes ambulatorios con enfermedad pulmonar obstructiva crónica estable. Arch Bronconeumol 40 (2004) 250-258
12. Alcolea S., Villamor J., and Álvarez-Sala R. EPOC y estado nutricional. Arch Bronconeumol 43 (2007) 283-288
13. Vermeeren M.A., Creutzberg E.C., Schols A.M., Postma D.S., Pieters W.R., Roldán A.C., et al. Prevalence of nutricional depletion in a large out-patient population of patients with COPD. Respir Med 100 (2006) 1349-1355
14. Coronel C., Orozco-Levi M., Ramirez-Sarmiento A., Martínez-Llorens J., Broquetas J., and Gea J. Síndrome de bajo peso asociado a la EPOC en nuestro medio. Arch Bronconeumol 38 (2002) 580-584
15. Broekhuizen R., Grimble R.F., Howell W.M., Shale D.J., Creutzberg E.C., Wouters E.F., et al. Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1ß - 511 single nucleotide polymorphism. Am J Clin Nutr 82 (2005) 1059-1064
16. Budweiser S., Heinemann F., Meyer K., Wild P.J., and Pfeifer M. Weight gain in caquectic COPD patients receiving non-invasive positive-pressure ventilation. Respir Care 51 (2006) 126-132
17. Franssen F.M.E., Sauerwein H.P., Rutten E.A.P., Wouters E.F.M., and Schols A.M. Whole-body resting and exercise-induced lipolysis in sarcopaenic patients with COPD. Eur Respir J 32 (2008) 1466-1471
18. Pitta F., Troosters T., Spruit M.A., Probst V.S., Decramer M., and Goselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171 (2005) 972-977
19. Ferreira I.M., Brooks D., Lacasse Y., Goldstein R.S., and White J. Nutritional supplementation for stable obstructive chronic pulmonary disease. Cochrane Database Syst Rev 2 (2005) CD000998
20. Casanova C., Cote C., De Torres J.P., Aguirre-Jaime A., Marín J.M., Pinto-Plata V., et al. The inspiratory to total lung capacity ratio predicts mortality in patients with COPD. Am J Respir Crit Care Med 171 (2005) 591-597
21. Gea J., and Barreiro E. Actualización en los mecanismos de disfunción muscular en la EPOC. Arch Bronconeumol 44 (2008) 328-337
22. Barreiro E., Schols A.M., Polkey M.I., Galdiz J.B., Gosker H.R., Swallow E.B., et al., ENIGMA in COPD project. Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax 63 (2008) 100-107
23. Savale L., Chaouat A., Bastuji-Garin S., Marcos E., Boyer L., Maitre B., et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 179 (2009) 566-571
24. Agustí A.G., Sauleda J., Miralles C., Gomez C., Togores B., Sala E., et al. Skeletal muscle apoptosis and weight loss inchronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 485-489
25. Ito K., and Barnes P.J. COPD as a disease of accelerated lung aging. Chest 135 (2009) 173-180
26. Landbo C., Prescott E., Lange P., Vestbo J., and Almdal T.P. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1856-1861
27. Celli B.R., Cote C., Marin J.M., Casanova C., Montes de Oca M., Mendez R., et al. The Body Mass Index, Airflow Obstruction, Dyspnea, Exercise Performance (BODE) Index in Chronic Obstructive Pulmonary Disease. N Engl J Med 350 (2004) 1005-1012
28. Schols A., Slangen J., Volovics L., and Wouters E. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1791-1797
29. Marquis K., Debigaré R., Lacasse Y., LeBlanc P., Jobin J., Carrier G., et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 809-813
30. Hallin R., Gudmundsson G., Suppli Ulrik C., Nieminen M.M., Gislason T., Lindberg E., et al. Nutritional status and long-term mortality in hospitalized patients with chronic obstructive pulmonary disease. Respir Med 101 (2007) 1954-1960
31. Martinez F.J., Foster G., Curtis J.L., Criner G., Weinmann G., Fishman A., et al., NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 173 (2006) 1326-1334
32. Jiang R., Paik D.C., Hankinson J.L., and Barr R.G. Cured meat consumption, lung function, and chronic obstructive pulmonary disease among USA adults. Am J Respir Crit Care Med 175 (2007) 798-804
33. Varraso R., Fung T., Barr R.G., Hu F.B., Willet W., and Camargo C.A. Prospective study of dietary patterns and chronic obstructive disease among US women. Am J Clin Nutr 86 (2007) 488-495
34. Varraso R., Fung T., Hu F.B., Willet W., and Camargo C.A. Prospective study of dietary patterns and chronic obstructive disease among US men. Thorax 62 (2007) 786-791
35. Broekhuizen R., Wouters E.F., Creutzberg E.C., Weling-Scheepers C.A., and Schols A.M. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax 60 (2005) 376-382
36. McKeever T.M., Lewis S.A., Smit H.A., Burney P., Cassano P.A., and Britton J. A multivariate analysis of serum nutrient levels and lung function. Respir Res 9 (2008) 67
37. Weisberg J., Wanger J., Olson J., Streit B., Fogarty C., Martin T., et al. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest 121 (2002) 1070-1078
38. Dentener M.A., Creutzberg E.C., Pennings H.J., Rijkers G.T., Mercken E., and Wouters E.F. Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study. Respiration 76 (2008) 275-282
39. Cosio B.G., Iglesias A., Rios A., Noguera A., Sala E., Ito K., et al. Low-dose of theophylline enhances the anti-inflamatory effect of steroids during exacerbations in chronic obstructive pulmonary disease. Thorax 64 (2009) 424-429
40. Casaburi R., Bhasin S., Cosentino L., Porszasz J., Somfay A., Lewis M.I., et al. Effects of testosteone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 (2004) 870-878
41. Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 128 (2005) 1187-1193